- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05820984
A Short SPIRIT Checklist for Peer Reviewers to Improve the Reporting Quality in Published Articles (SPIRIT-PR) (SPIRIT-PR)
Impact of a Short Form of the SPIRIT Checklist for Peer Reviewers to Improve the Reporting of Protocols for Randomised Controlled Trials Published in Biomedical Journals: a Randomised Controlled Trial (SPIRIT-PR)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom
- The BMJ Publishing Group
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria for journals:
It was planned from the beginning that this study will only be conducted at the BMJ Open as it publishes numerous protocols. Hence, no inclusion criteria for the journal were specified.
Inclusion criteria for manuscripts:
All submitted manuscripts sent out for external review that described protocols for RCTs.
Exclusion criterial for manuscripts:
We excluded (i) Manuscripts which were clearly labelled as a pilot or feasibility study (ii) Studies randomizing animals or cells (iii) Separate publications of data analysis plans
Included peer-reviewers:
-Peer reviewers that were invited following usual journal practice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SPIRIT checklist plus usual practice
After accepting to review an article, peer reviewers will receive the automated, journal specific standard email with general information as per each journal's usual practice (e.g.
where to access the manuscript, date when the peer review report is due).
In addition, peer-reviewers who received a manuscript which was randomised to the experimental arm will receive an additional email including a short version of the SPIRIT checklist together with a short explanation of those items.
|
Peer reviewer will be reminded of the following 10 CONSORT items (including a short description): Outcomes (12) Sample size (14) Recruitment (15) Allocation implementation (16 c) Blinding (17 a) Data collection methods (18 a) Data collection methods - retention (18 b) Statistical methods (20 a) Population analysed (20 c) Access to data (29) |
|
Other: Usual practice
After accepting to review an article, peer reviewers will receive the automated, journal specific standard email with general information as per each journal's usual practice.
|
Peer review as it is usual practice at the journal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completeness of reporting
Time Frame: Through study completion, an average of 1 year
|
The primary outcome of this study will be the difference of the mean proportion of adequately reported items of the 10 most important and poorly reported SPIRIT items between the two intervention arms.
|
Through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time from assigning an academic editor until the first decision (as communicated to the author after the first round of peer-review).
Time Frame: Through study completion, an average of 4 months; will be assessed from routinely collected data
|
Through study completion, an average of 4 months; will be assessed from routinely collected data
|
|
|
Proportion of articles directly rejected after the first round of peer-review
Time Frame: Through study completion, an average of 4 months; will be assessed from routinely collected data
|
Through study completion, an average of 4 months; will be assessed from routinely collected data
|
|
|
Proportion of articles published
Time Frame: Through study completion, an average of 9 months; will be assessed from routinely collected data
|
Through study completion, an average of 9 months; will be assessed from routinely collected data
|
|
|
Completeness of reporting
Time Frame: Through study completion, an average of 1 year
|
Mean proportion of adequate reporting of the 10 most important and poorly reported SPIRIT items, considering each sub-item as a separate item.
|
Through study completion, an average of 1 year
|
|
Completeness of reporting
Time Frame: Through study completion, an average of 1 year
|
Mean proportion for each of the 10 most important and poorly reported SPIRIT items separately (including also separate analysis of sub-items).
|
Through study completion, an average of 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peer reviewer comments for any reference to SPIRIT and trial reporting
Time Frame: Assessed from available peer-reviewer responses; on average 3 months after randomisation
|
For journals where peer reviewer comments are subsequently published alongside the published article, we will examine the peer reviewer comments for any reference to SPIRIT and trial reporting.
|
Assessed from available peer-reviewer responses; on average 3 months after randomisation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SPIRIT-PR 2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adequate Reporting in Published Study Protocols of Randomized Controlled Trials
-
University of OxfordCompletedAdequate Reporting in Randomized Controlled TrialsUnited States, United Kingdom
Clinical Trials on SPIRIT checklist plus usual practice
-
University of OxfordCompletedAdequate Reporting in Randomized Controlled TrialsUnited States, United Kingdom
-
Emory UniversityNational Institute on Aging (NIA)Completed
-
Emory UniversityNational Institute of Nursing Research (NINR); National Institute on Aging...Completed
-
University of IowaCompleted
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
Hospital Moinhos de VentoMinistry of Health, BrazilCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Susan G. Komen Breast Cancer FoundationCompletedActive Breast Cancer TreatmentUnited States
-
Johns Hopkins Bloomberg School of Public HealthMedstar Health Research Institute; Johns Hopkins Community PhysiciansCompletedCognitive ImpairmentUnited States
-
Emory UniversityNational Institute of Nursing Research (NINR)Completed
-
Lakehead UniversityDilico Anishinabek Family CareRecruitingDepression | Stress | Anxiety | Emotion RegulationCanada